BactiVax
BactiVax (anti-Bacterial Innovative Vaccines) is an innovative European Training Network that will provide high-level training in vaccinology to 15 high-achieving, creative Early Stage Researchers (ESRs), and equip them with a wide range of transferrable skills for thriving careers in vaccine research within academia and industry. BactiVax will focus on developing novel vaccines to tackle the huge challenge of antimicrobial-resistant human pathogens that cause chronic, life-threatening respiratory and/or systemic infections. This network comprises 14 Principal Investigators with expertise in vaccinology, proteomics, medicine, microbiology, biochemistry, immunology, structural biology, medicinal, peptide and glycochemistry from 8 European countries and two companies which will collectively train ESRs in entrepreneurship, commercial vaccine development and bioprocessing.
Participant organisations and principal investigators
University College Dublin (UCD, Dublin, Ireland) – Assoc. Prof. Siobhán McClean (2 positions)
National Research Council, Institute of Biostructures and Bioimaging (CNR-IBB, Naples, Italy) – Dr. Rita Berisio
Queens University Belfast (QUB, Belfast, UK) – Prof. Miguel Valvano
CIC bioGUNE | Center for Cooperative Research in Biosciences (Bilbao, Spain) – Prof. Juan Anguita
CIC bioGUNE | Center for Cooperative Research in Biosciences (Bilbao, Spain) – Prof. Jesús Jiménez-Barbero
St. George’s University of London (SGUL, London, UK) – Dr. Rajko Reljic
Ludwig Maximilian University of Munich (LMU, Munich, Germany) – Prof. Johannes Huebner
University of Milano Bicocca (UNIMIB, Milan, Italy) – Prof. Francesco Peri
Imperial College London (London, UK) – Prof. Rosemary Boyton and Prof. Danny Altmann (one position)
École Polytechnique Fédérale de Lausanne (EPFL, Lausanne, Switzerland) – Prof. Christian Heinis
Eötvös Loránd University (Budapest, Hungary) – Dr. Kata Horváti
LIONEX GmBH (Braunschweig, Germany) – Prof. Mahavir Singh
ImmunXperts (Gosselies, Belgium) – Dr. Séverine Giltaire
If you have any question please contact us
Lionex
© 2018 Lionex GmbH
Last update:
Lionex GmbHLIONEX GmbH